Crozet helps organizations to streamline and accelerate the development of new biological products against infectious diseases and cancer.
Crozet BioPharma is a multi-disciplinary team of development professionals with 10 successful product launches in the infectious disease space.
Crozet provides early-stage biotechnology companies with an alternative to hiring a costly personnel infrastructure and offers larger companies an alternative to diverting internal resources to development of a pipeline product. This approach ensures flexible use of resources, minimizes capital investment, and enhances return on investment. Crozet’s customers include public and private biopharmaceutical companies and non-profit organizations.